Compared to warfarin, direct oral anticoagulants are associated with lower mortality in patients with blunt traumatic intracranial hemorrhage: A TQIP study

Journal of Trauma and Acute Care Surgery

Volumn 81, Issue 5, 2016, Pages 843-848

  Feeney, James M ^a,b   Santone, Elizabeth ^b   Difiori, Monica ^c   Kis, Lilla ^c   Jayaraman, Vijay ^a,b   Montgomery, Stephanie C ^a,b  

^a SAINT FRANCIS HOSPITAL AND MEDICAL CENTER   (United States)

^b UNIVERSITY OF CONNECTICUT SCHOOL OF MEDICINE   (United States)

^c TRINITY COLLEGE   (United States)

Author keywords

anticoagulants; direct oral anticoagulants; traumatic brain injury; Traumatic intracranial hemorrhage

Indexed keywords

ANTICOAGULANT AGENT; WARFARIN; ANTITHROMBIN; BLOOD CLOTTING FACTOR 10A INHIBITOR;

AGED; ANTICOAGULANT THERAPY; ARTICLE; BRAIN HEMORRHAGE; CLINICAL OUTCOME; COMORBIDITY; CONTROLLED STUDY; FEMALE; HEART SURGERY; HOSPITAL DISCHARGE; HUMAN; HYPERTENSION; INJURY SEVERITY; INTENSIVE CARE UNIT; LENGTH OF STAY; MAJOR CLINICAL STUDY; MALE; MEDICAL RECORD REVIEW; MORTALITY RISK; NURSING HOME; PATIENT HISTORY OF SURGERY; PREDICTIVE VALUE; PRESCRIPTION; PRIORITY JOURNAL; RETROSPECTIVE STUDY; RISK REDUCTION; TRANSFUSION; TRAUMATIC BRAIN INJURY; BLEEDING; CHEMICALLY INDUCED; COMPARATIVE STUDY; INJURY SCALE; MORTALITY; ORAL DRUG ADMINISTRATION; REGISTER; REGRESSION ANALYSIS; TOTAL QUALITY MANAGEMENT;

ADMINISTRATION, ORAL; AGED; ANTICOAGULANTS; ANTITHROMBINS; FACTOR XA INHIBITORS; FEMALE; HEMORRHAGE; HUMANS; INTRACRANIAL HEMORRHAGE, TRAUMATIC; LENGTH OF STAY; MALE; QUALITY IMPROVEMENT; REGISTRIES; REGRESSION ANALYSIS; TRAUMA SEVERITY INDICES; WARFARIN;

EID: 84986183471     PISSN: 21630755     EISSN: 21630763     Source Type: Journal    
DOI: 10.1097/TA.0000000000001245     Document Type: Article

References (15)

1. Alonso A, Bengtson LG, MacLehose RF, Lutsey PL, Chen LY, Lakshminarayan K. Intracranial hemorrhage mortality in atrial fibrillation patients treated with dabigatran or warfarin. Stroke. 2014;45(8):2286-2291
2. Hagii J, Tomita H, Metoki N, Saito S, Shiroto H, Hitomi H, Kamada T, Seino S, Takahashi K, Baba Y, Sasaki S, Uchizawa T, Iwata M, Matsumoto S, Osanai T, Yasujima M, Okumura K. Characteristics of intracerebral hemorrhage during rivaroxaban treatment: comparison with those during warfarin. Stroke. 2014;45(9):2805-2807
3. Hankey GJ. Intracranial hemorrhage and novel anticoagulants for atrial fibrillation: what have we learned? Curr Cardiol Rep. 2014;16:480
4. Caldeira D, Barra M, Pinto FJ, Ferreira JJ, Costa J. Intracranial hemorrhage risk with the new oral anticoagulants: a systematic review and metaanalysis. J Neurol. 2015;262(3):516-522
5. Ruff CT, Giugliano RP, Braunwald E, Hoffman EB, Deenadayalu N, Ezekowitz MD, Camm AJ, Weitz JI, Lewis BS, Parkhomenko A, Yamashita T, Antman EM. Comparison of the efficacy and safety of neworal anticoagulants with warfarin in patients with atrial fibrillation: a meta-analysis of randomised trials. Lancet. 2014;383(9921):955-962
6. Sardar P, Chatterjee S,WuWC, Lichstein E, Ghosh J, Aikat S,Mukherjee D. Neworal anticoagulants are not superior towarfarin in secondary prevention of stroke or transient ischemic attacks, but lower the risk of intracranial bleeding: insights from a meta-analysis and indirect treatment comparisons. PLoS One. 2013;8(10):e77694
7. Lip GY, Larsen TB, Skjøth F, Rasmussen LH. Indirect comparisons of new oral anticoagulant drugs for efficacy and safety when used for stroke prevention in atrial fibrillation. J Am Coll Cardiol. 2012;60(8): 738-746
8. Hankey GJ, Stevens SR, Piccini JP, Lokhnygina Y, Mahaffey KW, Halperin JL, Patel MR, Breithardt G, Singer DE, Becker RC, Berkowitz SD, Paolini JF, Nessel CC, Hacke W, Fox KA, Califf RM, ROCKET AF Steering Committee and Investigators. Intracranial hemorrhage among patients with atrial fibrillation anticoagulated with warfarin or rivaroxaban: the rivaroxaban once daily, oral, direct factor Xa inhibition compared with vitamin K antagonismfor prevention of stroke and embolismtrial in atrial fibrillation. Stroke. 2014;45(5):1304-1312
9. Hart RG, Diener HC, Yang S, Connolly SJ, Wallentin L, Reilly PA, Ezekowitz MD, Yusuf S. Intracranial hemorrhage in atrial fibrillation patients during anticoagulation with warfarin or dabigatran: the RE-LY trial. Stroke. 2012;43(6):1511-1517
10. Beynon C, Potzy A, Sakowitz OW, Unterberg AW. Rivaroxaban and intracranial haemorrhage after mild traumatic brain injury: a dangerous combination? Clin Neurol Neurosurg. 2015;136:73-78
11. Beynon C, Sakowitz OW, Störzinger D, Orakcioglu B, Radbruch A, Potzy A, Unterberg AW. Intracranial haemorrhage in patients treated with direct oral anticoagulants. Thromb Res. 2015;136(3):560-565
12. Dempfle CE. Direct oral anticoagulants-pharmacology, drug interactions, and side effects. Semin Hematol. 2014;51(2):89-97
13. Gordon JL, Fabian TC, Lee MD, DugdaleM. Anticoagulant and antiplatelet medications encountered in emergency surgery patients: a review of reversal strategies. J Trauma Acute Care Surg. 2013;75(3):475-486
14. Centers for Disease Control and Prevention: Home and Recreational Safety: Data &Statistics Website http://www.cdc.gov/HomeandRecreationalSafety/ Falls/adultfalls.html. Accessed February 19, 2016
15. Miller SL,Miller S, Balon J, Helling TS. Medication reconciliation in a rural trauma population. Ann Emerg Med. 2008;52(5):483-491